197 related articles for article (PubMed ID: 31555846)
21. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI.
Wilson SR; Lyshchik A; Piscaglia F; Cosgrove D; Jang HJ; Sirlin C; Dietrich CF; Kim TK; Willmann JK; Kono Y
Abdom Radiol (NY); 2018 Jan; 43(1):127-142. PubMed ID: 28819825
[TBL] [Abstract][Full Text] [Related]
22. LI-RADS to categorize liver nodules in patients at risk of HCC: tool or a gadget in daily practice?
Barabino M; Gurgitano M; Fochesato C; Angileri SA; Franceschelli G; Santambrogio R; Mariani NM; Opocher E; Carrafiello G
Radiol Med; 2021 Jan; 126(1):5-13. PubMed ID: 32458272
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
Kim TK; Noh SY; Wilson SR; Kono Y; Piscaglia F; Jang HJ; Lyshchik A; Dietrich CF; Willmann JK; Vezeridis A; Sirlin CB
Clin Mol Hepatol; 2017 Dec; 23(4):280-289. PubMed ID: 28911220
[TBL] [Abstract][Full Text] [Related]
24. Impact of the Liver Imaging Reporting and Data System on Research Studies of Diagnosing Hepatocellular Carcinoma Using MRI.
Ahn Y; Choi SH; Jang JK; Kim SY; Shim JH; Lee SS; Byun JH
Korean J Radiol; 2022 May; 23(5):529-538. PubMed ID: 35289147
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
[TBL] [Abstract][Full Text] [Related]
26. Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS.
Hwang SH; Park S; Han K; Choi JY; Park YN; Park MS
Abdom Radiol (NY); 2019 Sep; 44(9):3078-3088. PubMed ID: 31165907
[TBL] [Abstract][Full Text] [Related]
27. Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study.
An C; Lee CH; Byun JH; Lee MH; Jeong WK; Choi SH; Kim DY; Lim YS; Kim YS; Kim JH; Choi MS; Kim MJ
Korean J Radiol; 2019 Dec; 20(12):1616-1626. PubMed ID: 31854149
[TBL] [Abstract][Full Text] [Related]
28. Computer-aided diagnosis program for classifying the risk of hepatocellular carcinoma on MR images following liver imaging reporting and data system (LI-RADS).
Kim Y; Furlan A; Borhani AA; Bae KT
J Magn Reson Imaging; 2018 Mar; 47(3):710-722. PubMed ID: 28556283
[TBL] [Abstract][Full Text] [Related]
29. LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features.
Alhasan A; Cerny M; Olivié D; Billiard JS; Bergeron C; Brown K; Bodson-Clermont P; Castel H; Turcotte S; Perreault P; Tang A
Abdom Radiol (NY); 2019 Feb; 44(2):517-528. PubMed ID: 30167771
[TBL] [Abstract][Full Text] [Related]
30. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma.
Kierans AS; Makkar J; Guniganti P; Cornman-Homonoff J; Lee MJ; Pittman M; Askin G; Hecht EM
J Magn Reson Imaging; 2019 Jun; 49(7):e205-e215. PubMed ID: 30257054
[TBL] [Abstract][Full Text] [Related]
31. The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.
Li J; Ling W; Chen S; Ma L; Yang L; Lu Q; Luo Y
Eur J Radiol; 2019 Nov; 120():108685. PubMed ID: 31606712
[TBL] [Abstract][Full Text] [Related]
32. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.
Potretzke TA; Tan BR; Doyle MB; Brunt EM; Heiken JP; Fowler KJ
AJR Am J Roentgenol; 2016 Jul; 207(1):25-31. PubMed ID: 26866746
[TBL] [Abstract][Full Text] [Related]
33. Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.
Barth BK; Donati OF; Fischer MA; Ulbrich EJ; Karlo CA; Becker A; Seifert B; Reiner CS
Acad Radiol; 2016 Sep; 23(9):1145-53. PubMed ID: 27174029
[TBL] [Abstract][Full Text] [Related]
34. LI-RADS 2017: An update.
Kielar AZ; Chernyak V; Bashir MR; Do RK; Fowler KJ; Mitchell DG; Cerny M; Elsayes KM; Santillan C; Kamaya A; Kono Y; Sirlin CB; Tang A
J Magn Reson Imaging; 2018 Jun; 47(6):1459-1474. PubMed ID: 29626376
[TBL] [Abstract][Full Text] [Related]
35. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
Smereka P; Doshi AM; Lavelle LP; Shanbhogue K
AJR Am J Roentgenol; 2020 Aug; 215(2):382-389. PubMed ID: 32432909
[No Abstract] [Full Text] [Related]
36. Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS.
Liu W; Qin J; Guo R; Xie S; Jiang H; Wang X; Kang Z; Wang J; Shan H
Acta Radiol; 2018 Feb; 59(2):140-146. PubMed ID: 28648125
[TBL] [Abstract][Full Text] [Related]
37. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.
An C; Rakhmonova G; Choi JY; Kim MJ
Clin Mol Hepatol; 2016 Jun; 22(2):296-307. PubMed ID: 27304548
[TBL] [Abstract][Full Text] [Related]
38. LI-RADS: Past, Present, and Future, From the
Marks RM; Masch WR; Chernyak V
AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
[TBL] [Abstract][Full Text] [Related]
39. LI-RADS categories: concepts, definitions, and criteria.
Santillan C; Chernyak V; Sirlin C
Abdom Radiol (NY); 2018 Jan; 43(1):101-110. PubMed ID: 29038857
[TBL] [Abstract][Full Text] [Related]
40. Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma.
Chen N; Motosugi U; Morisaka H; Ichikawa S; Sano K; Ichikawa T; Matsuda M; Fujii H; Onishi H
Magn Reson Med Sci; 2016; 15(1):49-59. PubMed ID: 26104079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
